CARLSBAD, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, announced today the acceptance of five abstracts at the 2024 American College of Rheumatology’s (ACR) annual meeting, ACR Convergence 2024, being held November 14-19, 2024, at the Walter E. Washington Convention Center in Washington, D.C.
Read more at globenewswire.comExagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
EXAGEN INC
NASDAQ:XGN (2/11/2025, 5:20:02 PM)
After market: 4.56 -0.23 (-4.8%)4.79
-0.01 (-0.21%)
XGN Latest News and Analysis
7 days ago - ChartmillTuesday's session: top gainers and losersStay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
